Search results
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 6 hours agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 12 hours agoShares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday,...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 1 day agoNovavax will receive $500 million in upfront payments as well as a further $700 million if all...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 1 day agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 4 days agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 5 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 1 week ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WKBN 27 Youngstown· 5 days ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 2 days ago:SASY) (NASDAQ:SNY), marking a significant milestone for the vaccine developer. The deal, which...